The Difficult-to-Treat del 17 p Patient—A Case Report in Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia (CLL) treatment strategies have evolved to include mechanism-driven drugs but now raise new questions regarding their optimum timing and sequencing. In high-risk patients, switching from pathway inhibitors to allogeneic stem cell transplantation (allo-HCT) is still a mat...

Descripción completa

Detalles Bibliográficos
Autores principales: Moldovianu, Ana-Maria, Crisan, Ana Manuela, Varady, Zsofia, Coriu, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778873/
https://www.ncbi.nlm.nih.gov/pubmed/35056341
http://dx.doi.org/10.3390/medicina58010033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778873/
https://www.ncbi.nlm.nih.gov/pubmed/35056341
http://dx.doi.org/10.3390/medicina58010033

Ejemplares similares